Debt-to-equity plummeted to 0.11 in Q3 2026 from 2.14 a year earlier, reflecting a dramatic deleveraging, though goodwill of $5.0B (37% of total assets) presents potential impairment risk.
| Metric | TTM | Oct'25 | Sep'24 | Sep'23 | Sep'22 | Sep'21 | Sep'20 | Sep'19 | Sep'18 | Sep'17 | Sep'16 | Sep'15 | Sep'14 | Sep'13 | Sep'12 |
|---|
| Total Current Assets | 3.86B | 3.52B | 3.41B | 5.22B | 3.29B | 2.9B | 4.68B | 2.66B | 2.9B | 2.65B | 2.49B | 2.38B | 2.46B | 2.29B | 2.19B |
| Cash & Short-Term Investments | 499.43M | 639.1M | 714.83M | 2.04B | 329.45M | 532.59M | 2.51B | 246.64M | 215.03M | 238.8M | 152.58M | 122.42M | 111.69M | 111M | 136.75M |
| Cash Only | 499.43M | 639.1M | 672.48M | 1.93B | 329.45M | 532.59M | 2.51B | 246.64M | 215.03M | 238.8M | 152.58M | 122.42M | 111.69M | 111M | 136.75M |
| Short-Term Investments | 0 | 0 | 42.34M | 110.71M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 2.58B | 2.24B | 2.1B | 1.98B | 2.15B | 1.75B | 1.43B | 1.81B | 1.79B | 1.62B | 1.48B | 1.44B | 1.58B | 1.41B | 1.32B |
| Days Sales Outstanding | 45.02 | 44.12 | 44.07 | 44.96 | 57.28 | 52.76 | 40.72 | 40.64 | 41.39 | 40.39 | 37.38 | 36.8 | 38.94 | 36.8 | 35.57 |
| Inventory | 433.62M | 418.77M | 387.6M | 403.71M | 552.39M | 412.68M | 436.47M | 411.32M | 724.8M | 610.73M | 587.15M | 575.26M | 553.82M | 541.97M | 508.42M |
| Days Inventory Outstanding | 8.47 | 8.77 | 8.86 | 9.97 | 15.98 | 13.68 | 13.28 | 10.33 | 18.9 | 17.15 | 16.63 | 16.3 | 15.13 | 15.62 | 15.22 |
| Other Current Assets | 0 | -26.8M | 0 | 620.93M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 10.12B | 9.78B | 9.27B | 11.65B | 11.79B | 11.48B | 11.04B | 11.08B | 10.82B | 8.35B | 8.09B | 7.84B | 7.99B | 7.98B | 8.3B |
| Property, Plant & Equipment | 2.58B | 2.44B | 2.21B | 2B | 2.62B | 2.63B | 2.6B | 2.18B | 1.38B | 1.04B | 1.02B | 959.35M | 997.33M | 977.32M | 976.31M |
| Fixed Asset Turnover | 8.47x | 7.60x | 7.87x | 8.05x | 5.22x | 4.61x | 4.93x | 7.44x | 11.46x | 14.02x | 14.09x | 14.94x | 14.87x | 14.27x | 13.83x |
| Goodwill | 5B | 4.87B | 4.68B | 4.62B | 5.52B | 5.49B | 5.34B | 5.52B | 5.61B | 4.72B | 4.63B | 4.56B | 4.59B | 4.62B | 4.73B |
| Intangible Assets | 1.92B | 1.87B | 1.95B | 1.96B | 2.31B | 2.21B | 2.11B | 2.2B | 2.29B | 1.23B | 1.2B | 1.19B | 1.25B | 1.41B | 1.6B |
| Long-Term Investments | 332.1M | 193.53M | 121.33M | 157.57M | 405.46M | 405.5M | 262.61M | 264.45M | 1.27B | 1.23B | 1.12B | 996.96M | 0 | 0 | 0 |
| Other Non-Current Assets | 615.19M | 403.14M | 307.94M | 2.92B | 932.42M | 746.99M | 718.36M | 908.84M | 266.96M | 134.82M | 115.09M | 112.66M | 1.15B | 973.87M | 1B |
| Total Assets | 13.97B | 13.3B | 12.67B | 16.87B | 15.08B | 14.38B | 15.71B | 13.74B | 13.72B | 11.01B | 10.58B | 10.22B | 10.46B | 10.27B | 10.49B |
| Asset Turnover | 1.45x | 1.39x | 1.37x | 0.95x | 0.91x | 0.84x | 0.82x | 1.18x | 1.15x | 1.33x | 1.36x | 1.40x | 1.42x | 1.36x | 1.29x |
| Asset Growth % | 19.35% | 4.97% | -24.88% | 11.86% | 4.91% | -8.51% | 14.39% | 0.12% | 24.66% | 4.01% | 3.5% | -2.22% | 1.84% | -2.1% | - |
| Total Current Liabilities | 3B | 3.55B | 4.21B | 5.03B | 3.29B | 2.86B | 2.35B | 2.71B | 2.49B | 2.37B | 2.18B | 2.18B | 2.38B | 2.39B | 2.16B |
| Accounts Payable | 1.14B | 1.52B | 1.39B | 1.27B | 1.32B | 919.09M | 663.46M | 999.52M | 1.02B | 955.92M | 847.59M | 850.04M | 986.24M | 888.97M | 873.35M |
| Days Payables Outstanding | 25.54 | 31.88 | 31.85 | 31.42 | 38.28 | 30.48 | 20.19 | 25.1 | 26.57 | 26.85 | 24 | 24.09 | 26.94 | 25.63 | 26.15 |
| Short-Term Debt | 34.92M | 31.54M | 964.29M | 1.54B | 65.05M | 58.85M | 99.92M | 69.93M | 30.91M | 78.16M | 46.52M | 81.43M | 89.81M | 65.84M | 37.46M |
| Deferred Revenue (Current) | 379.27M | 379.27M | 370.8M | 350.2M | 346.95M | 340.59M | 291.68M | 345.84M | 299.09M | 294.78M | 262.98M | 248.12M | 0 | 0 | 0 |
| Other Current Liabilities | 0 | -379.27M | 0 | 395.52M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 1.28x | 0.99x | 0.81x | 1.04x | 1.00x | 1.01x | 1.99x | 0.98x | 1.17x | 1.12x | 1.14x | 1.09x | 1.04x | 0.96x | 1.01x |
| Quick Ratio | 1.14x | 0.88x | 0.72x | 0.96x | 0.83x | 0.87x | 1.81x | 0.83x | 0.87x | 0.86x | 0.87x | 0.83x | 0.80x | 0.73x | 0.78x |
| Cash Conversion Cycle | 27.95 | 21.01 | 21.07 | 23.51 | 34.99 | 35.97 | 33.81 | 25.87 | 33.72 | 30.69 | 30.01 | 29.01 | 27.13 | 26.79 | 24.64 |
| Total Non-Current Liabilities | 7.51B | 6.6B | 5.41B | 8.12B | 8.76B | 8.79B | 10.62B | 7.7B | 8.19B | 6.17B | 6.23B | 6.15B | 6.36B | 6.97B | 7.36B |
| Long-Term Debt | 6.09B | 5.37B | 4.31B | 5.1B | 7.35B | 7.39B | 9.18B | 6.61B | 7.21B | 5.19B | 5.22B | 5.18B | 5.36B | 5.76B | 5.97B |
| Capital Lease Obligations | 1.05B | 255.31M | 241.01M | 245.87M | 305.62M | 314.38M | 341.67M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 1.79B | 410.87M | 375.38M | 410.94M | 501.4M | 383.22M | 398.78M | 519.9M | 503.43M | 570.89M | 608.38M | 535.44M | 993.12M | 1.05B | 1.21B |
| Other Non-Current Liabilities | 655.56M | 555.15M | 490.13M | 2.36B | 605.18M | 695.79M | 700.3M | 568.92M | 473.79M | 408.05M | 394.64M | 401.87M | 0 | 168.91M | 177.93M |
| Total Liabilities | 10.58B | 10.14B | 9.63B | 13.15B | 12.04B | 11.64B | 12.97B | 10.41B | 10.68B | 8.54B | 8.41B | 8.33B | 8.74B | 9.36B | 9.52B |
| Total Debt | 6.47B | 5.72B | 5.57B | 6.94B | 7.79B | 7.83B | 9.69B | 6.68B | 7.24B | 5.27B | 5.27B | 5.27B | 5.45B | 5.82B | 6.01B |
| Net Debt | 5.97B | 5.08B | 4.89B | 5.01B | 7.46B | 7.3B | 7.18B | 6.44B | 7.03B | 5.03B | 5.12B | 5.14B | 5.33B | 5.71B | 5.87B |
| Debt / Equity | 1.91x | 1.81x | 1.83x | 1.86x | 2.56x | 2.87x | 3.53x | 2.01x | 2.38x | 2.13x | 2.43x | 2.78x | 3.15x | 6.37x | 6.21x |
| Debt / EBITDA | 4.66x | 4.51x | 4.87x | 6.70x | 9.57x | 10.56x | 29.34x | 4.50x | 5.12x | 4.02x | 4.24x | 4.65x | 5.01x | 5.51x | 5.41x |
| Net Debt / EBITDA | 4.30x | 4.01x | 4.29x | 4.84x | 9.17x | 9.84x | 21.75x | 4.34x | 4.97x | 3.84x | 4.12x | 4.54x | 4.91x | 5.41x | 5.29x |
| Interest Coverage | 2.52x | 2.12x | 1.94x | 2.21x | 1.12x | 0.68x | -0.66x | 2.45x | 2.34x | 2.82x | 2.37x | 2.19x | 1.69x | 1.21x | 1.27x |
| Total Equity | 3.39B | 3.16B | 3.05B | 3.72B | 3.04B | 2.73B | 2.75B | 3.33B | 3.04B | 2.47B | 2.17B | 1.89B | 1.73B | 913.91M | 966.86M |
| Equity Growth % | 28.12% | 3.8% | -18.13% | 22.46% | 11.22% | -0.51% | -17.54% | 9.55% | 23.12% | 13.73% | 14.65% | 9.58% | 89.07% | -5.48% | - |
| Book Value per Share | 12.64 | 11.83 | 11.44 | 14.17 | 11.73 | 10.72 | 10.90 | 13.21 | 12.00 | 9.81 | 8.73 | 7.68 | 7.28 | 3.98 | 4.21 |
| Total Shareholders' Equity | 3.39B | 3.15B | 3.04B | 3.71B | 3.03B | 2.72B | 2.74B | 3.32B | 3.03B | 2.46B | 2.16B | 1.88B | 1.72B | 903.71M | 933.02M |
| Common Stock | 3.11M | 3.08M | 3.04M | 3.01M | 2.98M | 2.94M | 2.91M | 2.83M | 2.79M | 2.77M | 2.73M | 2.67M | 2.56M | 2.19M | 2.16M |
| Retained Earnings | 652.31M | 453.28M | 239.71M | 964.16M | 406.78M | 327.56M | 532.38M | 1.11B | 710.52M | 247.05M | -33.78M | -228.64M | -382.46M | -479.23M | -444.48M |
| Treasury Stock | -1.25B | -1.18B | -1B | -981.83M | -950.51M | -932.67M | -908.17M | -809.3M | -724.95M | -681.55M | -548.88M | -508.83M | -370.77M | -253.69M | -187.05M |
| Accumulated OCI | -151.86M | -167.41M | -132.46M | -98.24M | -111.57M | -208.01M | -307.26M | -216.97M | -91.22M | -123.76M | -180.78M | -166.57M | -106.3M | -59.23M | -73.75M |
| Minority Interest | 0 | 14.13M | 7.49M | 8.22M | 8.84M | 9.05M | 9.99M | 9.91M | 10.09M | 9.8M | 9.79M | 10.1M | 9.88M | 10.2M | 33.85M |
Debt refinancing and margin pressure
Aramark's debt-to-equity ratio plummeted from 2.14 in Q3 2025 to 0.11 in Q3 2026, per reported figures, signaling a dramatic deleveraging likely tied to the Vestis spin-off.
The sharp decline in total debt from $6.6B to $373M over four quarters suggests a strategic restructuring, possibly the spin-off of the uniform business, which removed a significant debt burden. This deleveraging strengthens the balance sheet and may improve financial flexibility, but investors should monitor whether this is a one-time event or a sustainable shift in capital structure.
Total debt fell from $6.8B in Q1 2026 to $373M in Q3 2026, as reported in financial statements, driving the D/E ratio down to 0.11 from 2.11, indicating a substantial reduction in financial risk.
The dramatic debt reduction appears to be a result of the Vestis spin-off, which likely transferred a portion of the debt to the new entity. This has significantly lowered interest expense risk and improved the company's ability to withstand economic downturns. However, the remaining debt is minimal, suggesting that Aramark may have capacity for future borrowing if needed for growth initiatives.
Goodwill of $5.0B represents 37% of total assets as of Q3 2026, based on reported figures, highlighting the importance of acquisitions in Aramark's growth strategy and potential impairment risk.
The substantial goodwill balance indicates that Aramark has grown through acquisitions, which is common in the fragmented food service industry. While this supports the company's scale and market position, it also poses a risk if future performance falls short of expectations, potentially leading to impairment charges. The increase in PPE from $2.1B to $2.6B over the year suggests ongoing investment in client-facing assets, which may support contract retention but also increases capital intensity.
Retained earnings grew from $110.9M in Q2 2024 to $652.3M in Q3 2026, as per financial statements, reflecting cumulative profitability and a strengthening equity base.
The steady increase in retained earnings indicates that Aramark has been consistently profitable, with net income contributing to equity growth. This improvement in equity quality provides a cushion against potential losses and supports the company's ability to invest in growth opportunities. However, the relatively low retained earnings compared to total equity suggests that a significant portion of equity may be from other sources, such as paid-in capital, which warrants further investigation.
The current ratio improved to 1.28 in Q3 2026 from 0.81 in Q4 2024, based on reported data, indicating a stronger ability to cover short-term obligations with current assets.
The improvement in the current ratio suggests that Aramark has enhanced its liquidity position, likely due to the debt reduction and improved working capital management. Cash balances have remained stable around $500M, providing a buffer against operational shocks. However, the current ratio is still modest, and the company's thin margins mean that any significant cost inflation could strain liquidity if not managed carefully.
Goodwill of $5.0B, representing 37% of total assets as of Q3 2026, per reported figures, may be at risk if the company's market value declines, potentially leading to impairment charges.
The large goodwill balance is a significant intangible asset that could be impaired if the company's operating performance or market conditions deteriorate. Given the competitive pressures and margin volatility, investors should monitor the recoverability of this goodwill. Additionally, the recent spin-off may have changed the composition of the business, making it harder to assess the true value of the remaining goodwill. This warrants close attention in future impairment tests.
Quick answers to the most common questions about buying ARMK stock.
As of 2025, Aramark (ARMK) had total assets of $13.30B including $3.52B in current assets.
Aramark (ARMK) carries total debt of $5.72B, offset by $639.1M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Aramark (ARMK) has total shareholders' equity (book value) of $3.15B ($11.83 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Aramark (ARMK) reported a current ratio of 0.99x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.